Related Experiment Video
Updated: Mar 28, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Molecular Mechanisms Underlying Pituitary Pathogenesis
Melanie Sapochnik1, Leandro Eduardo Nieto1, Mariana Fuertes1
1Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, C1425FQD, Buenos Aires, Argentina.
Abstract:
During the last years, progress has been made on the identification of mechanisms involved in anterior pituitary cell transformation and tumorigenesis. Oncogene activation, tumor suppressor gene inactivation, epigenetic changes, and microRNAs deregulation contribute to the initiation of pituitary tumors. Despite the high prevalence of pituitary adenomas, they are mostly benign, indicating that intrinsic mechanisms may regulate pituitary cell expansion. Senescence is characterized by an irreversible cell cycle arrest and represents an important protective mechanism against malignancy. Pituitary tumor transforming gene (PTTG) is an oncogene involved in early stages of pituitary tumor development, and also triggers a senescence response by activating DNA-damage signaling pathway. Cytokines, as well as many other factors, play an important role in pituitary physiology, affecting not only cell proliferation but also hormone secretion. Special interest is focused on interleukin-6 (IL-6) because its dual function of stimulating pituitary tumor cell growth but inhibiting normal pituitary cells proliferation. It has been demonstrated that IL-6 has a key role in promoting and maintenance of the senescence program in tumors. Senescence, triggered by PTTG activation and mediated by IL-6, may be a mechanism for explaining the benign nature of pituitary tumors.
Insights
Pituitary tumors remain benign due to senescence, a cell cycle arrest mechanism. Pituitary tumor transforming gene (PTTG) and interleukin-6 (IL-6) activate senescence, explaining the tumors
Area of Science:
- Endocrinology
- Oncology
- Cell Biology
Background:
- Pituitary tumors arise from genetic and epigenetic alterations.
- Most pituitary adenomas are benign, suggesting intrinsic regulatory mechanisms.
- Senescence is a cell cycle arrest that prevents malignancy.
Purpose of the Study:
- To investigate the role of senescence in pituitary tumor development.
- To explore the involvement of pituitary tumor transforming gene (PTTG) and interleukin-6 (IL-6) in pituitary tumor senescence.
- To understand the mechanisms underlying the benign nature of pituitary adenomas.
Main Methods:
- Analysis of mechanisms involved in anterior pituitary cell transformation and tumorigenesis.
- Investigation of oncogene activation, tumor suppressor gene inactivation, epigenetic changes, and microRNA deregulation.
- Study of the role of cytokines, specifically IL-6, in pituitary physiology and tumor growth.
Main Results:
- PTTG, an oncogene, triggers senescence by activating DNA-damage signaling.
- IL-6 exhibits dual function: stimulating tumor cell growth while inhibiting normal pituitary cell proliferation.
- IL-6 plays a key role in promoting and maintaining tumor senescence.
Conclusions:
- Senescence, induced by PTTG and mediated by IL-6, is a crucial mechanism explaining the benign nature of pituitary tumors.
- Understanding these pathways could offer insights into pituitary tumor management.
- Further research into senescence regulation in pituitary adenomas is warranted.
Related Concept Videos
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The Pituitary Gland
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Regulation of Hormone Secretion
Humoral...
Hypothalamic-Pituitary Axis

